The mhGAP guideline supports countries to strengthen capacity to deal with the growing burden of mental, neurological and substance use (MNS) conditions and narrow the treatment gap. This new edition includes 30 updated and 18 new recommendations, alongside 90 pre-existing recommendations.

This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings. It is for use by doctors, nurses, other health workers as well as health planners and managers.

Jun 24, 2019 · The WHO Mental Health Gap Action Programme (mhGAP) aims at scaling up services for mental, neurological and substance use disorders for countries especially with low- and middle-income.

mhGAP intervention guide for mental, neurological and sub- stance use disorders in non-specialized health settings: mental health Gap Action Programme (mhGAP) – version 2.0. 1.Mental Disorders - prevention and control. 2.Nervous System Diseases. 3.Psychotic Disorders. 4.Substance-Related Disorders. 5.Guideline. I.World Health Organization.

mhGAP is WHO’s action plan to scale up services for mental, neurological and substance use disorders for countries especially with low and lower middle incomes. The priority conditions addressed by mhGAP are: depression, schizophrenia and other psychotic disorders, suicide, epilepsy, dementia, disorders due to use of alcohol, disorders due to ...

WHO’s Mental Health Gap Action Programme (mhGAP) intervention guide (IG), provides evidence-based guidance and tools for assessment and integrated management of priority disorders. Our 2017 systematic review identified 33 peer-reviewed studies describing mhGAP-IG implementation in low-income and middle-income countries.

developed the Mental Health Gap Action Programme (mhGAP), to facilitate scaling up of care for MNS disorders. A key part of mhGAP is the evidence-based guideline, published in 2010 and available through the mhGAP Evidence Resource Centre (http://www.who.int/mental_health/mhgap/evidence/en/). The objectives of the guideline are:

WHO recognizes the need for action to reduce the burden, and to enhance the capacity of Member States to respond to this growing challenge. mhGAP is WHO’s action plan to scale up services for mental, neurological and substance use disorders for countries especially with low and lower middle incomes.

WHO recognizes the need for action to reduce the burden, and to enhance the capacity of Member States to respond to this growing challenge. mhGAP is WHO’s action plan to scale up services for mental, neurological and substance use disorders for countries especially with low and lower middle incomes.

An essential component of mhGAP is the evidence-based guideline for MNS disorders identified as conditions of high priority for low- and middle-income countries (LMICs). mhGAP was launched in 2008 and the first set of WHO recommendations was published in 2010 as part of the mhGAP intervention guide (2,6).